Loading...
Noradrenergic Dysfunction in Alzheimer's and Parkinson's Diseases—An Overview of Imaging Studies
Noradrenergic dysfunction contributes to cognitive impairment in Alzheimer's Disease (AD) and Parkinson's Disease (PD). Conventional therapeutic strategies seek to enhance cholinergic and dopaminergic neurotransmission in AD and PD, respectively, and few studies have examined noradrenergic...
Na minha lista:
| Udgivet i: | Front Aging Neurosci |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5938376/ https://ncbi.nlm.nih.gov/pubmed/29765316 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnagi.2018.00127 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|